The particulars: constipation · ten · dulaglutide.
I have done this once and I suspect I got away with it rather than got it right.
For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.
What is the correct sequence, and where is the step that people usually skip?
Week 10 is day 70: on a four-week ladder that is week 2 of dose step 3, and — at the seven-day half-life this class runs on — 10 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 70 is 5 weeks past it, which means the level is no longer the variable. That distinction is most of the question: at week 2 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Constipation is the one that does not follow the escalation curve. It builds with cumulative exposure and with the fall in food and fluid volume, so it characteristically appears later than nausea and outlasts it by months. Dose decisions are made under supervision, and nothing here is medical advice.
Answering this needs the actual fibre and fluid intake, and people are almost always taking less of both than they think.
Physical activity has a modest but real effect on transit time and is free, which makes it worth including even though it will not fix this on its own.
| Event | Active arm | Placebo arm | Timing |
|---|---|---|---|
| Nausea | 40–45 % | 15–20 % | Peaks 1–2 wk after each step |
| Vomiting | 15–25 % | 5–8 % | Follows nausea |
| Diarrhoea | 20–30 % | 10–15 % | Early, variable |
| Constipation | 20–25 % | 8–12 % | Later onset, persistent |
| Discontinuation for GI events | 4–7 % | 1–2 % | Mostly during escalation |
Ranges span agents and doses; read the specific prescribing information for a specific figure.
Osmotic agents such as macrogol draw water into the lumen and are the usual first pharmacological step; they work with the mechanism rather than against it.
The fibre-and-fluid relationship in functional constipation is established across intervention studies, and fibre without adequate fluid worsens symptoms.
Long-term stimulant laxative use is a clinical decision rather than a self-management default.
25 to 30 grams a day, deliberately planned, because it will not happen by accident.
edited 10 Feb 2025 by elke_brunner — added the method parameters
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswer first: constipation here is predominantly a reduced-intake problem — less food, less fibre, less fluid — before it is a motility problem.
Soluble fibre — psyllium, oats, legumes — holds water and softens stool. Insoluble fibre adds bulk and speeds transit. In slowed-transit constipation the soluble kind is generally the more useful of the two.
In practice, red flags that change this from a management question to a clinical one: no bowel movement for several days with abdominal distension and vomiting, blood in the stool, or unexplained weight loss beyond what is expected.
Research-use compounds are not approved for human use.
Fibre and fluid together. Fibre alone makes it worse and that is the commonest mistake.
The relevant mechanism is that slowed transit plus a smaller, drier stool is a combination that both reduces frequency and increases effort.
Aim for 25 to 30 grams of fibre a day, which requires deliberate planning at a reduced total intake because fibre-rich foods are bulky and satiating exactly when appetite is suppressed.
Adding fibre without adding fluid produces a larger, drier, harder stool and makes the problem worse. The fluid is not optional and is the step people skip.
Physical activity has a small measurable effect on colonic transit time in controlled studies.
Pain, distension and vomiting together are urgent. That is not constipation.
Put another way, this is the adverse effect that persists longest, because unlike nausea it does not attenuate with tolerance.
Magnesium-containing preparations act osmotically and are widely used; they are a laxative rather than a supplement in this context, and the dose is what makes the difference.
Osmotic first, stimulant reluctantly, and not as a standing arrangement.
Start with the three inputs: fibre grams, fluid volume and physical activity. Most cases resolve on the first two.
Stimulant laxatives are effective and are not a first choice for a problem that is going to persist for months, because of tolerance and dependence concerns with regular use.
Constipation is reported consistently across the trial programmes in this class, generally at rates below nausea, and does not show the same attenuation over time.
This one does not attenuate with tolerance. Plan for it rather than waiting it out.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.